Health Policy & Market Access
Advance your expertise in market access, health policy and healthcare management. Our training covers HTA and AMNOG processes, rebate agreement requirements, cooperation with statutory health insurers and healthcare supply management

Regulatory Strategy for ASEAN
This webcast series provides a practical overview of regulatory approval pathways, dossier requirements and market entry considerations for pharmaceutical products across key ASEAN markets. You will…Language: English
ExpertFORUM Global Regulatory Affairs
This online conference offers compact expert talks and diverse perspectives on global regulatory strategies, digital transformation and evidence generation. Expect focused insights, practical…Language: English
Pharma Marketing: Your Foundation for a Strong Start
This two-day online seminar gives newcomers to pharma marketing a solid, practice-oriented foundation. Participants learn how to translate insights into strategy, understand Market Access and digital…Language: English
US MFN Drug Pricing & European Market Access: Strategic Briefing for 2027
The US Most Favored Nation policy is already reshaping pharmaceutical pricing in Europe. Kristie Champlin Gurley, formerly with the US Department of Health and Human Services where she advised…Language: English
AI in Pharma: Foundations, Use Cases and Implementation in Europe
Learn how artificial intelligence is transforming the pharmaceutical industry in Europe. This foundation course covers AI concepts, key use cases, EU AI Act and GDPR essentials, GxP implications and…Language: English
Market Access & Healthcare Management Fundamentals
Market Access of innovative medicines in Europe - here you will learn the key concepts from strategy to roll-out.Language: English
Leveraging AI in Evidence Generation and Market Access
Using AI for clinical data evaluation, systematic literature reviews, dossier writing, and PICO simulations - the essential market access areas coveredLanguage: English
Market Access of Biosimilars in Europe
Biosimilar uptake in Europe, Aut idem in Germany - these are the challenges for regulatory affairs and market accessLanguage: English
Abonnement: PharmaFORUM Webcast International
Stay informed with updates from our global and local experts, who will provide the latest regulatory and legislative insights every two months. In 2026, topics will include CMC documentation,…Language: English
Repurposed drugs - Access to the European Market
This online seminar equips regulatory affairs, IP, legal and market access professionals with practical strategies to navigate the complex journey from drug repurposing to European market…Language: English
Leveraging AI in Evidence Generation and Market Access
Using AI for clinical data evaluation, systematic literature reviews, dossier writing, and PICO simulations - the essential market access areas coveredLanguage: English
Beyond HTA: Pricing Negotiations and Managed Entry Agreements across Europe
This seminar gives you a clear, comparative understanding of how innovative pricing and reimbursement agreements are structured and negotiated across the UK, Italy, France, Spain, and Germany.Language: English
e-Learning: AMNOG briefly and concisely
e-Learning in 5 modules: concept, data requirements and the AMNOG process up to the price negotiationLanguage: English
Contact
We are happy to provide you with personal and individual advice.
Our professional development portfolio is extensive. We would be pleased to discuss your requirements with you personally and help identify the most suitable options from our range of offerings. Let our professional development experts advise you and feel free to contact us today.

Dr. Henriette Wolf-Klein
Head of Department Healthcare
+49 6221 500-680
h.wolf-klein@forum-institut.de